in this issue
People & Business :: M&A
Meiji to acquire Indian contract manufacturing and generic drugs firm Medreich for $290 million
June 12, 2014 | Natasha Alperowicz
Meiji Holdings (Tokyo), through its Meiji Seika Pharma subsidiary, has agreed to acquire Bangalore, India based Medreich Ltd. Meiji agreed to pay $290 million for Medreich, which in 2013 reported sales of $157 million and operating income of $24 million. The agreement is with Med Holdings (Weybridge, UK), Nokha Holdings (Bangalore) and V-Sciences Investments (Singapore), the major shareholders in Medreich. Medreich, established in 1973, has manufacturing facilities in India and is a contract manufacturing organization (CMO) and contract development and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee